Mass malaria treatment trial aims to wipe out hidden infections in ghanaian communities

This study will give a combination of two malaria drugs (dihydroartemisinin-piperaquine and primaquine) to entire communities in Ghana every two months for two years. The goal is to see if this approach can reduce the number of people carrying malaria parasites, even those with no symptoms. About 9,000 people aged 3 months and older will take part, and the results will help guide national malaria policy.